Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation

Maidina Tuohetahuntila, Martijn R. Molenaar, Bart Spee, Jos F. Brouwers, Richard Wubbolts, Martin Houweling, Cong Yan, Hong Du, Brian C. VanderVen, Arie B. Vaandrager, J. Bernd Helms

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Activation of hepatic stellate cells (HSCs) is a critical step in the development of liver fibrosis. During activation, HSCs lose their lipid droplets (LDs) containing triacylglycerols (TAGs), cholesteryl esters, and retinyl esters (REs). We previously provided evidence for the presence of two distinct LD pools, a preexisting and a dynamic LD pool. Here we investigate the mechanisms of neutral lipid metabolism in the preexisting LD pool. To investigate the involvement of lysosomal degradation of neutral lipids, we studied the effect of lalistat, a specific lysosomal acid lipase (LAL/Lipa) inhibitor on LD degradation in HSCs during activation in vitro. The LAL inhibitor increased the levels of TAG, cholesteryl ester, and RE in both rat and mouse HSCs. Lalistat was less potent in inhibiting the degradation of newly synthesized TAG species as compared with a more general lipase inhibitor orlistat. Lalistat also induced the presence of RE-containing LDs in an acidic compartment. However, targeted deletion of the Lipa gene in mice decreased the liver levels of RE, most likely as the result of a gradual disappearance of HSCs in livers of Lipa/ mice. Lalistat partially inhibited the induction of activation marker -smooth muscle actin (-SMA) in rat and mouse HSCs. Our data suggest that LAL/Lipa is involved in the degradation of a specific preexisting pool of LDs and that inhibition of this pathway attenuates HSC activation.

Original languageEnglish (US)
Pages (from-to)12436-12448
Number of pages13
JournalJournal of Biological Chemistry
Volume292
Issue number30
DOIs
StatePublished - Jan 1 2017

Fingerprint

Hepatic Stellate Cells
Lysosomes
Chemical activation
Lipids
Degradation
Esters
Sterol Esterase
Liver
Triglycerides
Cholesterol Esters
Rats
Gene Deletion
Lipid Droplets
Lipase
Lipid Metabolism
Liver Cirrhosis
Corrosion inhibitors
Muscle
Actins
Genes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Tuohetahuntila, M., Molenaar, M. R., Spee, B., Brouwers, J. F., Wubbolts, R., Houweling, M., ... Helms, J. B. (2017). Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation. Journal of Biological Chemistry, 292(30), 12436-12448. https://doi.org/10.1074/jbc.M117.778472

Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation. / Tuohetahuntila, Maidina; Molenaar, Martijn R.; Spee, Bart; Brouwers, Jos F.; Wubbolts, Richard; Houweling, Martin; Yan, Cong; Du, Hong; VanderVen, Brian C.; Vaandrager, Arie B.; Helms, J. Bernd.

In: Journal of Biological Chemistry, Vol. 292, No. 30, 01.01.2017, p. 12436-12448.

Research output: Contribution to journalArticle

Tuohetahuntila, M, Molenaar, MR, Spee, B, Brouwers, JF, Wubbolts, R, Houweling, M, Yan, C, Du, H, VanderVen, BC, Vaandrager, AB & Helms, JB 2017, 'Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation', Journal of Biological Chemistry, vol. 292, no. 30, pp. 12436-12448. https://doi.org/10.1074/jbc.M117.778472
Tuohetahuntila M, Molenaar MR, Spee B, Brouwers JF, Wubbolts R, Houweling M et al. Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation. Journal of Biological Chemistry. 2017 Jan 1;292(30):12436-12448. https://doi.org/10.1074/jbc.M117.778472
Tuohetahuntila, Maidina ; Molenaar, Martijn R. ; Spee, Bart ; Brouwers, Jos F. ; Wubbolts, Richard ; Houweling, Martin ; Yan, Cong ; Du, Hong ; VanderVen, Brian C. ; Vaandrager, Arie B. ; Helms, J. Bernd. / Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation. In: Journal of Biological Chemistry. 2017 ; Vol. 292, No. 30. pp. 12436-12448.
@article{3348e36e883d45d3a7aff5bbdd08d8ce,
title = "Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation",
abstract = "Activation of hepatic stellate cells (HSCs) is a critical step in the development of liver fibrosis. During activation, HSCs lose their lipid droplets (LDs) containing triacylglycerols (TAGs), cholesteryl esters, and retinyl esters (REs). We previously provided evidence for the presence of two distinct LD pools, a preexisting and a dynamic LD pool. Here we investigate the mechanisms of neutral lipid metabolism in the preexisting LD pool. To investigate the involvement of lysosomal degradation of neutral lipids, we studied the effect of lalistat, a specific lysosomal acid lipase (LAL/Lipa) inhibitor on LD degradation in HSCs during activation in vitro. The LAL inhibitor increased the levels of TAG, cholesteryl ester, and RE in both rat and mouse HSCs. Lalistat was less potent in inhibiting the degradation of newly synthesized TAG species as compared with a more general lipase inhibitor orlistat. Lalistat also induced the presence of RE-containing LDs in an acidic compartment. However, targeted deletion of the Lipa gene in mice decreased the liver levels of RE, most likely as the result of a gradual disappearance of HSCs in livers of Lipa/ mice. Lalistat partially inhibited the induction of activation marker -smooth muscle actin (-SMA) in rat and mouse HSCs. Our data suggest that LAL/Lipa is involved in the degradation of a specific preexisting pool of LDs and that inhibition of this pathway attenuates HSC activation.",
author = "Maidina Tuohetahuntila and Molenaar, {Martijn R.} and Bart Spee and Brouwers, {Jos F.} and Richard Wubbolts and Martin Houweling and Cong Yan and Hong Du and VanderVen, {Brian C.} and Vaandrager, {Arie B.} and Helms, {J. Bernd}",
year = "2017",
month = "1",
day = "1",
doi = "10.1074/jbc.M117.778472",
language = "English (US)",
volume = "292",
pages = "12436--12448",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "30",

}

TY - JOUR

T1 - Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation

AU - Tuohetahuntila, Maidina

AU - Molenaar, Martijn R.

AU - Spee, Bart

AU - Brouwers, Jos F.

AU - Wubbolts, Richard

AU - Houweling, Martin

AU - Yan, Cong

AU - Du, Hong

AU - VanderVen, Brian C.

AU - Vaandrager, Arie B.

AU - Helms, J. Bernd

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Activation of hepatic stellate cells (HSCs) is a critical step in the development of liver fibrosis. During activation, HSCs lose their lipid droplets (LDs) containing triacylglycerols (TAGs), cholesteryl esters, and retinyl esters (REs). We previously provided evidence for the presence of two distinct LD pools, a preexisting and a dynamic LD pool. Here we investigate the mechanisms of neutral lipid metabolism in the preexisting LD pool. To investigate the involvement of lysosomal degradation of neutral lipids, we studied the effect of lalistat, a specific lysosomal acid lipase (LAL/Lipa) inhibitor on LD degradation in HSCs during activation in vitro. The LAL inhibitor increased the levels of TAG, cholesteryl ester, and RE in both rat and mouse HSCs. Lalistat was less potent in inhibiting the degradation of newly synthesized TAG species as compared with a more general lipase inhibitor orlistat. Lalistat also induced the presence of RE-containing LDs in an acidic compartment. However, targeted deletion of the Lipa gene in mice decreased the liver levels of RE, most likely as the result of a gradual disappearance of HSCs in livers of Lipa/ mice. Lalistat partially inhibited the induction of activation marker -smooth muscle actin (-SMA) in rat and mouse HSCs. Our data suggest that LAL/Lipa is involved in the degradation of a specific preexisting pool of LDs and that inhibition of this pathway attenuates HSC activation.

AB - Activation of hepatic stellate cells (HSCs) is a critical step in the development of liver fibrosis. During activation, HSCs lose their lipid droplets (LDs) containing triacylglycerols (TAGs), cholesteryl esters, and retinyl esters (REs). We previously provided evidence for the presence of two distinct LD pools, a preexisting and a dynamic LD pool. Here we investigate the mechanisms of neutral lipid metabolism in the preexisting LD pool. To investigate the involvement of lysosomal degradation of neutral lipids, we studied the effect of lalistat, a specific lysosomal acid lipase (LAL/Lipa) inhibitor on LD degradation in HSCs during activation in vitro. The LAL inhibitor increased the levels of TAG, cholesteryl ester, and RE in both rat and mouse HSCs. Lalistat was less potent in inhibiting the degradation of newly synthesized TAG species as compared with a more general lipase inhibitor orlistat. Lalistat also induced the presence of RE-containing LDs in an acidic compartment. However, targeted deletion of the Lipa gene in mice decreased the liver levels of RE, most likely as the result of a gradual disappearance of HSCs in livers of Lipa/ mice. Lalistat partially inhibited the induction of activation marker -smooth muscle actin (-SMA) in rat and mouse HSCs. Our data suggest that LAL/Lipa is involved in the degradation of a specific preexisting pool of LDs and that inhibition of this pathway attenuates HSC activation.

UR - http://www.scopus.com/inward/record.url?scp=85026312722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026312722&partnerID=8YFLogxK

U2 - 10.1074/jbc.M117.778472

DO - 10.1074/jbc.M117.778472

M3 - Article

C2 - 28615446

AN - SCOPUS:85026312722

VL - 292

SP - 12436

EP - 12448

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 30

ER -